2.36 USD
+0.01 (+0.43%)
ChartMill assigns a Buy % Consensus number of 85% to NRBO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.2. This target is 1052.54% above the current price.
NRBO was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NRBO.
In the previous month the buy percentage consensus was at a similar level.
NRBO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-08 | Maxim Group | Initiate | Buy |
| 2022-12-07 | Ladenburg Thalmann | Initiate | Buy |
NEUROBO PHARMACEUTICALS INC / NRBO FAQ
What do analysts expect the price target to be for NEUROBO PHARMACEUTICALS INC (NRBO)?
8 analysts have analysed NRBO and the average price target is 27.2 USD. This implies a price increase of 1052.54% is expected in the next year compared to the current price of 2.36.
What is the consensus rating for NEUROBO PHARMACEUTICALS INC (NRBO) stock?
The consensus rating for NEUROBO PHARMACEUTICALS INC (NRBO) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.